Guillain-Barré syndrome in a cancer patient treated with bevacizumab.

Taguchi, Daiki; Kamada, Sachiko; Yoshida, Taichi; Fukuda, Koji; Shimazu, Kazuhiro; Inoue, Masahiro; Sugawara, Masashiro; Nanjyo, Hiroshi; Iijima, Katsunori; Shibata, Hiroyuki

Taguchi, Daiki; Kamada, Sachiko; Yoshida, Taichi; Fukuda, Koji; Shimazu, Kazuhiro; Inoue, Masahiro; Sugawara, Masashiro; Nanjyo, Hiroshi; Iijima, Katsunori; Shibata, Hiroyuki.

Afiliación

Taguchi D; Department of Clinical Oncology , Akita, Japan.
Kamada S; Department of Gastroenterology & Neurology, Akita, Japan.
Yoshida T; Department of Clinical Oncology , Akita, Japan.
Fukuda K; Department of Clinical Oncology , Akita, Japan.
Shimazu K; Department of Clinical Oncology , Akita, Japan.
Inoue M; Department of Clinical Oncology , Akita, Japan.
Sugawara M; Department of Gastroenterology & Neurology, Akita, Japan.
Nanjyo H; 3Department of Pathology, Akita University, Akita, Japan.
Iijima K; Department of Gastroenterology & Neurology, Akita, Japan.
Shibata H; Department of Clinical Oncology , Akita, Japan.

Int Cancer Conf J ; 7(3): 87-92, 2018 Jul.

Article en En | MEDLINE | ID: mdl-31149522

Palabras clave

Bevacizumab; Breast cancer; GuillainBarré syndrome; StewartTreves syndrome

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Int Cancer Conf J Año: 2018 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google